Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology

C Domingues, A Santos, C Alvarez-Lorenzo… - ACS …, 2022 - ACS Publications
Worldwide nanotechnology development and application have fueled many scientific
advances, but technophilic expectations and technophobic demands must be …

Translating 3D printed pharmaceuticals: From hype to real-world clinical applications

I Seoane-Viaño, SJ Trenfield, AW Basit… - Advanced Drug Delivery …, 2021 - Elsevier
Abstract Three-dimensional (3D) printing is a revolutionary technology that is disrupting
pharmaceutical development by enabling the production of personalised printlets (3D …

Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine

MAS Weerink, MMRF Struys, LN Hannivoort… - Clinical …, 2017 - Springer
Dexmedetomidine is an α 2-adrenoceptor agonist with sedative, anxiolytic, sympatholytic,
and analgesic-sparing effects, and minimal depression of respiratory function. It is potent …

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

K Dheda, T Gumbo, G Maartens, KE Dooley… - The lancet Respiratory …, 2017 - thelancet.com
Global tuberculosis incidence has declined marginally over the past decade, and
tuberculosis remains out of control in several parts of the world including Africa and Asia …

Developmental changes in pharmacokinetics and pharmacodynamics

J van den Anker, MD Reed, K Allegaert… - The Journal of …, 2018 - Wiley Online Library
Effective drug therapy to optimally influence disease requires an understanding of a drug's
pharmacokinetic, pharmacodynamic, and pharmacogenomic interrelationships. In …

Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines

EC de Baat, RL Mulder, S Armenian… - Cochrane Database …, 2022 - cochranelibrary.com
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer
receiving anthracyclines - de Baat, EC - 2022 | Cochrane Library Skip to Content Cookies Our …

Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology

OD Howes, M Rogdaki, JL Findon… - Journal of …, 2018 - journals.sagepub.com
An expert review of the aetiology, assessment, and treatment of autism spectrum disorder,
and recommendations for diagnosis, management and service provision was coordinated …

Developmental pharmacokinetics in pediatric populations

H Lu, S Rosenbaum - The Journal of Pediatric …, 2014 - meridian.allenpress.com
Information on drug absorption and disposition in infants and children has increased
considerably over the past 2 decades. However, the impact of specific age-related effects on …

Management of opioid analgesic overdose

EW Boyer - New England Journal of Medicine, 2012 - Mass Medical Soc
Management of Opioid Analgesic Overdose | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Clinical standards for the dosing and management of TB drugs

JWC Alffenaar, SL Stocker, LD Forsman… - … of Tuberculosis and …, 2022 - ingentaconnect.com
BACKGROUND: Optimal drug dosing is important to ensure adequate response to
treatment, prevent development of drug resistance and reduce drug toxicity. The aim of …